The published studies are mostly related to NF2 or malignant peripheral nerve sheath tumors, and these studies report a difference in the PD‐L1‐positivity rate in these cancers (Perry et al., 2019; Shurell et al., 2016; Wang et al., 2018). Here, CD274 is linked to cancer.